CONMED Corporation (CNMD)

Debt-to-equity ratio

Sep 30, 2025 Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 1,008,260 1,002,870 977,636 962,681 932,896 881,832 854,664 834,222 796,205 780,194 752,453 745,545 716,337 672,968 789,546 785,435 755,683 744,499 725,570 709,038
Debt-to-equity ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

September 30, 2025 calculation

Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $1,008,260K
= 0.00


Peer comparison

Sep 30, 2025

Company name
Symbol
Debt-to-equity ratio
CONMED Corporation
CNMD
0.00
Abbott Laboratories
ABT
0.00
Stryker Corporation
SYK
0.00